Home › Neuroendocrine Tumors

Neuroendocrine Tumors clinical trials recruiting in the U.S.

40 studies for Neuroendocrine Tumors are recruiting participants at sites across the United States.

Cities with the most studies

• Washington, DC11 studies
• Philadelphia, PA11 studies
• Rochester, MN9 studies
• Houston, TX8 studies
• Salt Lake City, UT8 studies
• St. Louis, MO8 studies
• Columbus, OH8 studies
• Detroit, MI7 studies
• Cedar Rapids, IA7 studies
• Cleveland, OH7 studies
• Miami, FL7 studies
• New York City, NY7 studies
• Lexington, KY7 studies
• Chicago, IL7 studies
• Portland, OR6 studies
• Omaha, NE6 studies
• Dallas, TX6 studies
• Charlottesville, VA6 studies
• Nashville, TN6 studies
• Los Angeles, CA5 studies
• Milwaukee, WI5 studies
• Tampa, FL5 studies
• Atlanta, GA5 studies
• Mountain View, CA5 studies
• Seattle, WA5 studies
• Jacksonville, FL5 studies
• Grand Rapids, MI5 studies
• Boston, MA5 studies
• San Francisco, CA5 studies
• Ann Arbor, MI4 studies
• Fargo, ND4 studies
• Phoenix, AZ4 studies
• Durham, NC4 studies
• Arlington, VA4 studies
• Buffalo, NY4 studies
• Baldwin Park, CA4 studies
• Baltimore, MD4 studies
• Kansas City, MO3 studies
• Akron, OH3 studies
• Hartford, CT3 studies

By state

• Alabama3 studies
• Arizona7 studies
• California14 studies
• Colorado4 studies
• Connecticut5 studies
• Florida12 studies
• Georgia6 studies
• Illinois8 studies
• Iowa8 studies
• Kentucky7 studies
• Louisiana6 studies
• Maryland13 studies
• Massachusetts7 studies
• Michigan11 studies
• Minnesota11 studies
• Missouri9 studies
• Nebraska6 studies
• New Mexico3 studies
• New York9 studies
• North Carolina5 studies
• North Dakota4 studies
• Ohio14 studies
• Oregon6 studies
• Pennsylvania12 studies
• Tennessee7 studies
• Texas11 studies
• Utah8 studies
• Virginia7 studies
• Washington5 studies
• Wisconsin7 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.